eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected..". plemmons added, "particularly in a time when mental health resources for children appear to be static, and woefully scarce across the u.s"..